Description

Boldenone 300 by PharmaQo is a pharmaceutical-grade injectable solution delivering 300 mg/mL Boldenone Undecylenate, a long-acting anabolic compound primarily used in veterinary medicine but sometimes researched in human contexts for its potential in treating muscle-wasting conditions and anemia under controlled clinical study.

Boldenone provides a slow and steady release due to its long undecylenate ester, with mild androgenic and anabolic effects, making it of research interest in muscle preservation and red blood cell stimulation.

Product Details:
Active Ingredient:

• Boldenone Undecylenate

Concentration: 300 mg/mL

Form: Injectable solution (intramuscular)

Vial Size: 10 mL multidose vial

Pharmacokinetics:
Boldenone Undecylenate has an approximate half-life of 14 days, allowing for administration every 1–2 weeks, depending on study design.

Usage Recommendations:

• Indications (Research Context): Muscle-wasting disorders, anemia, tissue repair (primarily veterinary use; human use under research protocols only)

• Typical Dosage (Research Use): Variable, often 200–400 mg every 1–2 weeks in study settings

• Monitoring: Hematocrit, hemoglobin, liver enzymes, lipid profile, androgenic markers

• Cycle/Duration: As outlined in research protocols; long-acting and accumulates over time

Disclaimer:
This product is intended strictly for research and educational purposes. It is not approved for human consumption or therapeutic use without formal clinical approval. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with contraindicated medical conditions. Always follow local laws and research regulations.